EFFECTS ON PRURITUS AND SLEEP DISTURBANCE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AFTER 1 YEAR OF TREATMENT WITH SELADELPAR, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AGONIST: RESULTS OF AN OPEN-LABEL PHASE 2 STUDY
Kremer, AE; Mayo, MJ; Bowlus, CL; Neff, G; Swain, MG; Galambos, M; Trivedi, AGP; Hirschfield, G; Aspinall, R; Gordon, SC; Borg, BB; Harrison, S; Thuluvath, P; Jones, DE; Doerffel, Y; Levy, C; Stanca, C; Sheridan, D; Vierling, JM; Shiffman, ML; Odin, J; Bacon, B; Hassanein, T; Thorburn, D; Berg, C; Bernstein, D; Gulamhusein, A; Landis, C; Peyton, A; Corless, L; Buggisch, P; Worns, MA; Bergheanu, S; Varga, M; Li, Y; Yang, K; Dickinson, K; Boudes, P; McWherter, CA; Steinberg, A; Choi, YJ
GASTROENTEROLOGY, 2020; 158 (6): S1284
